Telaprevir-based triple therapy following partial splenic arterial embolization for chronic hepatitis C with thrombocytopenia can reduce carcinogenesis and improve hepatic function...

Por ISHIKAWA, TORU, ABE, SATOSHI, KOJIMA, YUICHI, HORIGOME, RYOKO, SANO, TOMOE, IWANAGA, AKITO, SEKI, KEIICHI, HONMA, TERASU, YOSHIDA, TOSHIAKI
Publicado no Exp Ther Med (2015)

Clinical efficacy of the highly sensitive hepatitis C virus RNA quantitative assay in patients with relapse following interferon-based therapy with second-generation direct-acting...

Por ISHIKAWA, TORU, ABE, SATOSHI, WATANABE, TAKAYUKI, NOZAWA, YUJIRO, SANO, TOMOE, IWANAGA, AKITO, SEKI, KEIICHI, HONMA, TERASU, YOSHIDA, TOSHIAKI
Publicado no Biomed Rep (2016)

Improved survival with double platinum therapy transcatheter arterial infusion using cisplatin and transcatheter arterial chemoembolization using miriplatin for BCLC-B hepatocellul...

Por Ishikawa, Toru, Abe, Satoshi, Watanabe, Takayuki, Nozawa, Yujiro, Sano, Tomoe, Iwanaga, Akito, Seki, Keiichi, Honma, Terasu, Yoshida, Toshiaki
Publicado no Mol Clin Oncol (2016)

Percutaneous transhepatic obliteration and percutaneous transhepatic sclerotherapy for intractable hepatic encephalopathy and gastric varices improves the hepatic function reserve

Por Ishikawa, Toru, Imai, Michitaka, Ko, Masayoshi, Sato, Hiroki, Nozawa, Yujiro, Sano, Tomoe, Iwanaga, Akito, Seki, Keiichi, Honma, Terasu, Yoshida, Toshiaki
Publicado no Biomed Rep (2017)

Effect of treatment support on preventing local recurrence of hepatocellular carcinoma directly adjacent to the diaphragm

Por Ishikawa, Toru, Imai, Michitaka, Ko, Masayoshi, Sato, Hiroki, Nozawa, Yujiro, Sano, Tomoe, Iwanaga, Akito, Seki, Keiichi, Honma, Terasu, Yoshida, Toshiaki
Publicado no Mol Clin Oncol (2017)

Evaluation of the branched-chain amino acid-to-tyrosine ratio prior to treatment as a prognostic predictor in patients with liver cirrhosis

Por Ishikawa, Toru, Imai, Michitaka, Ko, Masayoshi, Sato, Hiroki, Nozawa, Yujiro, Sano, Tomoe, Iwanaga, Akito, Seki, Keiichi, Honma, Terasu, Yoshida, Toshiaki
Publicado no Oncotarget (2017)

Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment

Por Ishikawa, Toru, Imai, Michitaka, Owaki, Takashi, Sato, Hiroki, Nozawa, Yujiro, Sano, Tomoe, Iwanaga, Akito, Seki, Keiichi, Honma, Terasu, Yoshida, Toshiaki
Publicado no Intern Med (2018)

Eosinophilic esophagitis in Japanese patients: A mild and slow-progressing disorder

Por Sato, Hiroki, Honma, Terasu, Nozawa, Yujiro, Owaki, Takashi, Imai, Michitaka, Sano, Tomoe, Iwanaga, Akito, Seki, Keiichi, Ishikawa, Toru, Yoshida, Toshiaki, Terai, Shuji
Publicado no PLoS One (2018)

Prediction of a sustained viral response in chronic hepatitis C patients who undergo induction therapy with double filtration plasmapheresis plus interferon-β/ribavirin

Por ISHIKAWA, TORU, ABE, SATOSHI, KOJIMA, YUICHI, SANO, TOMOE, IWANAGA, AKITO, SEKI, KEI-ICHI, HONMA, TERASU, YOSHIDA, TOSHIAKI, YAMAZAKI, MIHOKO, SAKAI, TAKEHITO, TASAKI, KAZUYUKI, SUZUKI, YASUSHI
Publicado no Exp Ther Med (2015)